AC
Applied Clinical Trials
ACT Brief: Who Sets Trial Endpoints, Human-Centered Trial Execution, and Bladder Cancer Approval Expansion
0:00-1:50
In today’s ACT Brief, we examine who decides what trials measure, how designing for human thinking improves site execution, and how the FDA extended an immunotherapy to a new bladder cancer population.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8965444
Published
October 16, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#setstrialendpoints #centeredtrialexecution #bladdercancerapproval #lifesciences
